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Abstract Patients with Parkinson’s disease (PD) are
likely to become physically inactive, because of their
motor, mental, and emotional symptoms. However, specific
studies on physical activity in PD are scarce, and results are
conflicting. Here, we quantified daily physical activities in
a large cohort of PD patients and another large cohort of
matched controls. Moreover, we investigated the influence
of disease-related factors on daily physical activities in PD
patients. Daily physical activity data of PD patients
(n = 699) were collected in the ParkinsonNet trial and of
controls (n = 1,959) in the Longitudinal Aging Study
Amsterdam (LASA); data were determined using the
LAPAQ, a validated physical activity questionnaire. In
addition, variables that may affect daily physical activities
in PD were recorded, including motor symptoms, depres-
sion, disability in daily life, and comorbidity. Patients were
physically less active; a reduction of 29% compared to
controls (95% CI, 10–44%). Multivariate regression anal-
yses demonstrated that greater disease severity, gait
impairment, and greater disability in daily living were
associated with less daily physical activity in PD
(R2 = 24%). In this large study, we show that PD patients
are about one-third less active compared to controls. While
disease severity, gait, and disability in daily living pre-
dicted part of the inactivity, a portion of the variance
remained unexplained, suggesting that additional determi-
nants may also affect daily physical activities in PD.
Because physical inactivity has many adverse conse-
quences, work is needed to develop safe and enjoyable
exercise programs for patients with PD.
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Introduction
Patients with Parkinson’s disease (PD) are likely to expe-
rience a decrease in their daily physical activity, because of
physical impairments, fatigue, and apathy. Such a seden-
tary lifestyle is undesirable, because physical inactivity is a
risk factor for cardiovascular disease, diabetes mellitus,
cognitive impairment, osteoporosis, and depression [40].
Moreover, physical inactivity may worsen various non-
motor symptoms, such as insomnia and constipation.
Thus far, only a few studies have examined physical
activity in PD, and the results were inconsistent. Several
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studies found reduced levels of physical activity, but
activity levels were not assessed optimally (either indi-
rectly using visual analogous scales [12], or using activity
monitors mounted at the wrist, rather than the leg [37]), or
studies were very small [5, 35]. Unexpectedly, two studies
found that patients and controls spent comparable amounts
of time being active [7, 29].
The determinants of physical activity in PD remain
incompletely understood [11]. Generic factors such as age
[16], gender [6, 16], and health status [16] are associated with
the level of physical activity in healthy adults. Furthermore,
depression is a risk factor for developing a sedentary lifestyle
[30]. Such factors may also affect exercise behavior in
patients with PD. Identifying the determinants of physical
activity may help to structure new exercise interventions.
Here, we quantified daily physical activities in a large
group of PD patients and analyze the associated determi-
nants, using data from the ParkinsonNet trial (699 patients)
[24, 25] and the population-based LASA study (1,959
controls) [10].
Methods
Participants
Patients
The ParkinsonNet trial was a cluster randomized trial
involving 699 participants that evaluated community-based
professional networks of physiotherapists (ParkinsonNet)
[24, 25]. Eligibility criteria for patients were the following:
(a) PD according to the UK PDS Brain Bank criteria [13];
(b) living independently in the community; (c) \80 years
old; (d) able to complete the questionnaires; (e) MMSE [23;
and (f) no severe comorbidity interfering with daily func-
tioning. Stage of the disease was scored according to the
original Hoehn and Yahr (H&Y) stages [17]. Most patients
(81.6%) had moderate disease severity (i.e., H&Y 2–3;
Table 1). Mean age was 68.6 ± 7.7 years, 409 patients were
men (58.5%), and average disease duration was 5.3 years.
Full ethical approval has been granted for the study. All
patients signed informed consent. In the study described
here, we used baseline data.
Controls
Controls were derived from the Longitudinal Aging Study
Amsterdam (LASA), a prospective study of persons aged
55–85 years old (1995–1996) [10]. This cohort forms a
nationally representative sample of the older Dutch popu-
lation and, thus, creates a good control group. After
exclusion of participants older than 80 years, data of 1,959
controls were available for the analyses. Mean age was
65.8 ± 7.0 years and 921 subjects were men (47.0%)
(Table 1). Full ethical approval has been granted for the
study and all respondents gave informed consent at the start
of the study.
Daily physical activity in patients and controls
In both groups, daily physical activity was measured with
the LASA Physical Activity Questionnaire (LAPAQ) [33].
The LAPAQ covers frequency and duration of different
activities during the previous 2 weeks [33, 39]. Activities
covered in the LAPAQ include the following: walking
outside, cycling, gardening, light and heavy household
activities, and a maximum of two sport activities. To
consider different levels of intensity of activities, a meta-
bolic equivalent value (MET) was assigned to each activity
to calculate the number of kilocalories spent per day per
kilogram of body weight [1]. In addition, types of different
activities (‘inside’ and ‘outside the house’) were specified.
The LAPAQ was initially designed as an interview-
based physical activity questionnaire; in the LASA study,
data were collected this manner. A self-completed version
was used in the ParkinsonNet trial. To reduce recall bias,
the time window was limited to 1 week. A random sample
of the ParkinsonNet trial population (n = 76) completed
the questionnaire and was also interviewed similar to the
controls. The subgroup was comparable to the total PD
population (Table 1).
Disease-related factors associated with daily physical
activity in PD
In the ParkinsonNet trial, a wide range of variables were
assessed: disease severity (H&Y stages and motor section
of the unified Parkinson’s Disease Rating Scale [23]), fear
of falling (Falls Efficacy Scale-International [34]), anxiety
and depression (Hospital Anxiety and Depression Scale
[21]), mobility (timed up and go test [22]), freezing of gait
(Freezing of Gait questionnaire [14]), walking speed (6-m
walk test), disability in daily life (Self-assessment Parkin-
son’s Disease Disability Scale [3]), comorbidity (cumula-
tive illness rating scale [26]), and ‘‘faller status’’ (C1 fall in
the preceding year). Patient characteristics included gen-
der, age, education level, and marital status. We studied the
influence of these disease-related factors on daily physical
activity. We classified six dimensions to analyze all fac-
tors: demographics (gender, age, education level, and mar-
ital status); health status/disease severity (H&Y, UPDRS,
CIRS, and time since diagnosis); walking performance/
mobility (TUG, FOGQ, and walking speed); fear of falling,
anxiety, and depression (HADS and FES-I); disability in
daily life (SPDDS); and faller status.
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Analyses
Data of daily physical activity in both groups were sum-
marized with medians and 25th and 75th percentiles. Since
the LAPAQ scores were skewed, linear logarithmic trans-
formation was applied for all subsequent analyses. Differ-
ences between patients and controls in minutes per day as
well as in kilocalories per day were evaluated using linear
regression analyses, with adjustment for gender, age, edu-
cation level, and marital status. Furthermore, linear
regression analysis with forward variable selection was
performed to study the association between the dimensions
mentioned above and daily physical activities. First, we
used a stepwise selection procedure to identify additional
variables that contributed significantly. In addition, we
used a hierarchic approach whereby in each subsequent
step of the selection procedure, an F test was performed for
each dimension that was not yet in the model. First, the
demographic variables were included in the model. The
dimension with the smallest p value was then included,
provided that it was statistically significant. The selection
procedure was stopped when the F test of none of the
remaining dimensions was significant. A two-sided p value
of\0.05 was considered to indicate statistical significance.
In general, selection procedures provide a model, but they
do not guarantee that the model is unique. Therefore, we
evaluated whether the resulting model was optimal and
unique by calculating the explained variance (R2) for all
possible alternative models.
Results
Daily physical activity in PD compared to controls
Patients spent 111 min/day (interquartile range 58–206) on
daily physical activity, compared to 150 min for controls
(interquartile range 89–232). This amount led to a 29%
reduction in patients versus controls (95% CI, 10–44%;
p \ 0.01). Patients also spent 29% fewer kilocalories
during daily physical activity (95% CI, 11–43%; p \ 0.01).
After adjustment for age, gender, education level, and
marital status, the difference between patients and controls
was 24% (95% CI, 3–40%; p \ 0.05). In contrast to the
control group, the patient population included subjects
younger than 55 years of age. Therefore, we performed an
additional analysis excluding patients younger than
55 years old, which showed comparable results.
In a subanalysis, we specified the nature of activities.
Median time spent to ‘outdoor and sports activities’ did not
differ between patients and controls (95% CI, 79–150%).
However, PD patients spent significantly less time to
activities inside the house (62%; 95% CI, 45–83%;
p \ 0.01).
Table 1 Characteristics of the
participants
Data are mean (SD) or number
(%)
Patients Controls
Total population Random sample
N 699 76 1959
Men 409 (58.5%) 44 (57.9%) 921 (47.0%)
Age 68.6 (±7.7) 67.6 (±8.2) 65.8 (±7.0)
Time since diagnosis 5.3 (±4.7) 3.9 (±3.7)
Education level
Low 385 (55.1%) 26 (34.2%) 1243 (63.5%)
Medium 112 (16.0%) 16 (21.1%) 367 (18.8%)
High 150 (21.5%) 25 (32.9%) 349 (17.8%)
Missing 52 (7.4%) 9 (11.8%) 0 (0.0%)
Partner
Yes 522 (74.7%) 54 (71.1%) 1451 (74.1%)
No 131 (18.6%) 13 (17.1%) 508 (25.9%)
Missing 46 (6.7%) 9 (11.8%) 0 (0.0%)
Hoehn & Yahr
1 77 (11.0%) 7 (9.2%)
2 327 (46.8%) 36 (47.4%)
3 243 (34.8%) 25 (32.9%)
4 34 (4.9%) 7 (9.2%)
Missing 18 (2.6%) 1 (1.3%)
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Disease-related factors associated with daily physical
activities in PD
Univariate relationships
Univariate regression analyses were performed to investi-
gate the relation between the various disease-related factors
and daily physical activity in minutes per day (Table 2). All
disease-related factors were significantly correlated with
daily physical activity, except for ‘time since diagnosis’.
Compared to men, women with PD were 80% more
active. Furthermore, time spent on daily physical activity
decreased significantly with age (-3% for each year) and
with disease severity (-3% for each point on the UPDRS).
Figure 1 shows that the time spent on daily physical activity
decreased when disease severity increased. In addition,
patients without falls in the preceding year spent 32% more
time on daily activity compared to fallers. Greater fear of
falling, comorbidity, and depression and anxiety were
associated with less daily physical activity in PD.
Multivariate relationships
Stepwise model selection resulted in a model with four vari-
ables: gender, comorbidity, mobility, and disability in daily
life (Table 2). This model explained 22% of the variance.
However, when we checked whether this model was
unique, we found ten additional models leading to 21%
explained variance. In addition, the model with three
variables (gender, mobility, and disability in daily life) had
an explained variance of 21%. All models with five or
more variables explained at least 20% of the variance,
whereas the percentage explained variance of the full
model was 24%. We evaluated the possible collinearity in
Table 2 Regression coefficients (%) and 95% confidence intervals for univariate and multivariate analyses between daily physical activities and
the explanatory factors
Covariate Univariate regression
(95% CIs)
Multivariate regression
Demographics
Age (years) -3 (-5, -2)*
Gender (women versus men) 80 (44, 125)* 101 (65, 141)
Education level (low, medium, high) -5 (-17, 9)
Marital status (partner versus no partner) 6 (-20, 39)
Health status/disease severity
H&Y Stage -34 (-43, -23)*
UPDRS III (0–108) -3 (-4, -2)*
CIRS (0–56) -28 (-38, -17)* -18 (-29, -9)
Time since diagnosis (years) -2 (-4.5, 0.3)
Walking performance/mobility
TUG (time in s) -10 (-13, -8)* -7 (-10, -4)
FOGQa (0–20) -19 (-28, -10)*
Walking speed (speed in m/s) 184 (50, 389)*
Fear of falling, anxiety and depression
FES-Ia (16–64) -65 (-74, -52)*
HADS depression (0–21) -7 (-9, -4)*
HADS anxiety (0–21) -4 (-7, -1)*
Disability in daily life
SPDDSa (24–120) -82 (-87, -73)* -63 (-75, -45)
Faller status
Faller status (no versus yes) 32 (6, 65)*
H&Y stage Hoehn and Yahr stage, UPDRS Unified Parkinson’s Disease Rating Scale, CIRS cumulative illness rating scale, TUG timed up and go
test, FOGQ freezing of Gait questionnaire, FES-I Falls Efficacy Scale-International, HADS Hospital Anxiety and Depression Scale, SPDDS self-
assessment Parkinson’s Disease Disability Scale
a Linear logarithmic transformation was applied; the coefficients presented here indicate the effect of doubling of the score, e.g., when fear of
falling increased by a factor 2, daily physical activities decreased by 65%
* Significant relationship between the independent factor and daily physical activities
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the full model. The largest collinearity index was 3.9 and
the largest variance inflation factor (VIF) was 2.6. Only
SPDDS and FES-I had a VIF exceeding 2.
Multivariate relationships: hierarchic approach
As we could not find a reasonably unique model in the
multivariable approach, we used a hierarchic variable
selection to identify dimensions which were associated
with daily physical activity. Demographic characteristics
were first included in the multivariate regression model
and explained a small portion of the variance (R2 = 9%).
The subsequent model selection procedure for dimen-
sions of health resulted in a model with the dimensions
walking performance/mobility, disability in daily life,
and health status/disease severity. These dimensions, in
addition to demographics, jointly explained 24% of the
variance in LAPAQ scores (Table 3). Adding more
dimensions into the model did not increase the explained
variance. This final model was not unique: Table 3
shows that various other models yielded only slightly
lower R2.
Discussion
Patients with PD are widely presumed to follow a seden-
tary lifestyle, due to their physical, cognitive, and emo-
tional impairments. We now provide new evidence to
underpin this assumption, based on analyses of time spent
on daily physical activity in a large cohort of PD patients
and another large cohort of controls. The loss of time spent
on activities was most obvious in patients with greater
disease severity.
Our results showed that PD patients were 29% less
active compared to controls. In a previous study of 24,000
subjects aged 65 years and older, similarly reduced activity
levels (by about 23%) were found for patients with a
chronic disease such as musculoskeletal disorders and
vascular or heart diseases [2]. The 29% reduction observed
for PD patients in the present study might even be greater
in comparison with healthy controls since our cohort did
not include severely affected PD patients [24]. Moreover,
the LASA study, which we used as a control group, showed
that about 60% of the population had a chronic disease
[39]. Direct comparison for comorbidity between the two
groups was not possible as the LASA study only recorded
broad categories and did not subdivide in specific disor-
ders. Although it would be interesting incorporating fall
histories in the analysis, data of fall history was not
available for the control group. Future studies are required
to investigate the influence of these factors.
It is important to consider the methods used to assess
physical activity in the present and other studies. We used
a validated interview-based physical activity questionnaire
[33], which is a subjective method of measuring physical
activity. This might have resulted in an overestimation of
the reported physical activity. However, this possible
overestimation likely applies equally to both patients and
controls, so it is unlikely that this influenced our results.
Another possibility is that patients underestimated their
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Fig. 1 Levels of daily physical activities per Hoehn & Yahr Stage
(H&Y); the error bars reflect the 95% confidence intervals. *decrease
is significant compared to H&Y 1
Table 3 Models with their explained variance (R2); all models were adjusted for demographic characteristics
One dimension R2 (%) Two dimensions R2 (%) Three dimensions R2 (%)
ADL 19 Walking, ADL 23 Severity, walking, ADL 24
Walking 18 Severity, ADL 21 FoF & anxiety, walking, ADL 23
Severity 15 Severity, walking 20 Walking, falls, ADL 23
Falls 15 FoF & anxiety, ADL 20 Severity, FoF & anxiety, ADL 22
FoF & anxiety 10 Falls, ADL 19 Severity, falls, ADL 21
Classified dimensions: Severity Health status/disease severity, Walking walking performance/mobility, FoF & anxiety fear of falling, anxiety and
depression, ADL disability in daily life, Falls faller status
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activity due to memory problems. However, patients with
severe cognitive impairment (MMSE \ 24) were excluded,
so this is unlikely to explain the physical inactivity observed
in PD patients. Other studies circumvented such problems by
using objective measures of physical activity; these studies
did not find differences between patients and controls [7, 11,
37]. Although these activity monitors have been well vali-
dated and shown to be reliable for a range of activities, some
specific activities such as gardening and cycling are difficult
to quantify [9, 20, 41]. This may be one reason for the dis-
crepancy with our results.
We also investigated the determinants associated with
daily physical activity in PD patients. One factor was
gender. Univariate regression analysis showed that women
with PD were 80% more active than men. This is in con-
trast with observations in non-PD populations [16]. The
LAPAQ assessed a broad range of activities, including
walking outside, cycling, gardening, light and heavy
household activities, and a maximum of two sport activi-
ties. When we removed the household activities from the
total activity score, men appeared to be more physically
active than women (p \ 0.01). The same effect was found
in the control group. This suggests that women spent more
time to daily activities because the LAPAQ records
household activities. Another study found comparable
results for older women: two-thirds of them reached rec-
ommended levels of physical activity when domestic
activities were included in the assessment, but only 21%
when these domestic activities were excluded [19].
We also found several additional determinants associ-
ated with daily physical activity. Specifically, inactivity in
PD was associated with worse walking performance, more
disability in daily life, and greater disease severity. These
factors identified in this study for PD are comparable to
other studies that investigated the determinants of physical
inactivity in older persons [2, 6, 32].
Our results concerning the determinants of daily physical
activity in PD have to be interpreted with some caution for
several reasons. First, the final model was not unique,
because various different combinations of determinants
yielded almost the same percentage of explained variance. A
model with two dimensions (i.e., walking performance and
disability in daily life) was as good as a model with three
dimensions (additionally including either disease severity,
fear of falling, anxiety and depression, or faller status).
Second, in all models, the unexplained variance
remained large. Our final model explained 24% of the
variance. Adding more variables into the model did not
increase the explained variance. This suggests that addi-
tional factors are responsible for the variability in LAPAQ
scores in PD. Because we secondarily analyzed data from
two previous trials, various factors were not investigated.
One such factor is fatigue, which may be an independent
contributor to physical inactivity in PD [11]. Moreover,
social cognitive theories propose that behavioral factors are
associated with physical activity [28, 32]. Earlier work
showed that a model which included self-efficacy and out-
come expectations, explained 64% of the variance in
exercise behavior in older adults [28]. Other studies found
that (lack of) interest in physical activity, knowledge about
the benefits of exercise, and social supports also predicted
exercise behavior [8, 28, 32]. In the literature, many other
possible determinants have been suggested, ranging from
income and socioeconomic status up to seasonal effects
[30, 31, 36]. Further work, therefore, remains necessary to
identify ‘all’ determinants, as a basis for future therapeutic
interventions.
Although we showed that physical inactivity was most
obvious in patients with greater disease severity, not all PD
patients with advanced disease were completely sedentary.
This suggests that even PD patients in later stages of the
disease might be stimulated to become more active. Par-
ticipating in regular physical activity would be particularly
useful for PD patients, because exercise may help to pre-
vent cardiovascular events, diabetes mellitus, and osteo-
porosis [40]. Moreover, in older subjects, physical activity
was reported to suppress typical PD symptoms such as
depression and cognitive decline [4, 18]. In addition, pre-
clinical evidence in animals with experimental parkinson-
ism suggests that exercise may directly alter the
neurodegenerative process in PD [27]. A meta-analysis
found exercise to be effective at improving physical
functioning, health-related quality of life, strength, balance,
and gait speed for people with PD [15]. It is, therefore,
important for PD patients to avoid a sedentary lifestyle.
Simply informing people about the health benefits of
physical activity is likely insufficient to attain a sustained
behavioral change. Motivational aspects are especially
important because such behavioral interventions could
target motivation to increase levels of physical activity. We
are now testing this in the ParkFit trial, a large exercise
study involving 586 PD patients randomized to receive a
behavioral change program aimed to increase daily physi-
cal activity levels. The ParkFit trial uses motivational
strategies and personal health coaches to induce a lasting
increase in exercise behavior for patients with PD; the first
results are expected in 2012 [38].
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